Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial-Reference-Cited by-同舟云学术

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Published:2014-03 Issue:9923 Volume:383 Page:1138-1146
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Palfi Stéphane,Gurruchaga Jean Marc,Ralph G Scott,Lepetit Helene,Lavisse Sonia,Buttery Philip C,Watts Colin,Miskin James,Kelleher Michelle,Deeley Sarah,Iwamuro Hirokazu,Lefaucheur Jean Pascal,Thiriez Claire,Fenelon Gilles,Lucas Cherry,Brugières Pierre,Gabriel Inanna,Abhay Kou,Drouot Xavier,Tani Naoki,Kas Aurelie,Ghaleh Bijan,Le Corvoisier Philippe,Dolphin Patrice,Breen David P,Mason Sarah,Guzman Natalie Valle,Mazarakis Nicholas D,Radcliffe Pippa A,Harrop Richard,Kingsman Susan M,Rascol Olivier,Naylor Stuart,Barker Roger A,Hantraye Philippe,Remy Philippe,Cesaro Pierre,Mitrophanous Kyriacos A

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Epidemiology of Parkinson's disease;de Lau;Lancet Neurol,2006

2. Etiology and pathogenesis of Parkinson disease;Schapira;Neurol Clin,2009

3. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?;Di Monte;Lancet Neurol,2003

4. Enhancing aromatic L-amino acid decarboxylase activity: implications for L-dopa treatment in Parkinson's disease;Hadjiconstantinou;CNS Neurosci Ther,2008

5. Tyrosine hydroxylase and regulation of dopamine synthesis;Daubner;Arch Biochem Biophys,2011

Cited by 364 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for polygenic or complex diseases;Biomarker Research;2024-09-04

2. Microglia-specific IL-10 gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson’s disease;Science Translational Medicine;2024-08-21

3. Neurosurgical gene therapy for central nervous system diseases;Neurotherapeutics;2024-07

4. The efficacy and safety of gene therapy approaches in Parkinson's disease: A systematic review;Disease-a-Month;2024-07

5. Stem cell therapeutics and gene therapy for neurologic disorders;Neurotherapeutics;2024-07